Literature DB >> 29353712

Cost-utility of collaborative nurse-led self-management support for primary care patients with anxiety, depressive or somatic symptoms: A cluster-randomized controlled trial (the SMADS trial).

Thomas Grochtdreis1, Thomas Zimmermann2, Egina Puschmann2, Sarah Porzelt2, Judith Dams3, Martin Scherer2, Hans-Helmut König3.   

Abstract

BACKGROUND: Anxiety, depressive and somatoform disorders are highly prevalent and cause a huge economic burden. A nurse-led collaborative care intervention has been set up in order to improve self-management of patients with these mental disorders in primary care in Hamburg, Germany. The aim of this study was to determine the cost-utility of this nurse-led intervention from the health care payer perspective.
METHODS: This analysis was part of a 12-month cluster-randomized controlled trial aiming to increase perceived self-efficacy of primary care patients with anxiety, depressive or somatic symptoms by collaborative nurse-led self-management support compared with routine care. A cost-effectiveness analysis using quality-adjusted life years was performed. Net-monetary benefit regressions adjusted for baseline differences for different willingness-to-pay thresholds were conducted and cost-effectiveness acceptability curves were constructed.
RESULTS: In total, n = 325 patients (intervention group: n = 134; control group: n = 191) with a mean age of 40 from 20 primary care practices were included in the analysis. The adjusted differences in quality-adjusted life years and mean total costs between intervention group and control group were +0.02 and +€1145, respectively. Neither of the two differences was statistically significant. The probability for cost-effectiveness of the complex nurse-led intervention was 49% for a willingness-to-pay of €50,000 per additional quality-adjusted life year. The probability for cost-effectiveness did not exceed 65%, independent of the willingness-to-pay.
CONCLUSION: The complex nurse-led intervention promoting self-management for primary care patients with anxiety, depressive or somatic symptoms did not prove to be cost-effective relative to routine care from a health care payer perspective.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety disorders; Collaborative care; Cost-utility analysis; Depressive disorders; Nurses; Primary care; Quality-adjusted life years; Somatoform disorders

Mesh:

Year:  2017        PMID: 29353712     DOI: 10.1016/j.ijnurstu.2017.12.010

Source DB:  PubMed          Journal:  Int J Nurs Stud        ISSN: 0020-7489            Impact factor:   5.837


  1 in total

1.  Psychometric evaluation of the German version of the Recovering Quality of Life (ReQoL) measures in patients with affective disorders.

Authors:  Thomas Grochtdreis; Hans-Helmut König; Anju Devianee Keetharuth; Jürgen Gallinat; Alexander Konnopka; Holger Schulz; Martin Lambert; Anne Karow; Judith Dams
Journal:  Eur J Health Econ       Date:  2022-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.